Phio Pharmaceuticals (PHIO) Receivables - Other (2011 - 2012)

Phio Pharmaceuticals' (PHIO) quarterly Receivables - Other came in at $597000.0 in Q1 2012, little changed on a QoQ basis from $597000.0 in Q4 2011.

Phio Pharmaceuticals (PHIO) Receivables - Other (2011 - 2012) Analysis & Trends

Phio Pharmaceuticals (PHIO) has 2 years of Receivables - Other data on file, last reported at $597000.0 in Q1 2012.

Quarterly Receivables - Other changed N/A year-over-year to $597000.0 in Q1 2012, while the trailing twelve-month figure through Mar 2012 was $597000.0 (changed N/A YoY) and the FY2011 annual result came in at $597000.0, changed N/A from the prior year.
Receivables - Other steadied at $597000.0 in Q1 2012, from $597000.0 in the prior quarter.
In the past five years, Receivables - Other ranged from a high of $597000.0 in Q4 2011 to a low of $597000.0 in Q4 2011.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)
1	Vertex Pharmaceuticals	137.11 Bn	129.26 Bn	2.84 Bn
2	Regeneron Pharmaceuticals	84.98 Bn	76.99 Bn	3.93 Bn
3	Argenx Se	64.52 Bn	59.33 Bn	1.37 Bn
4	Moderna	53.23 Bn	48.09 Bn	52.00 Mn
5	BeOne Medicines	41.23 Bn	36.14 Bn	1.53 Bn
6	Alnylam Pharmaceuticals	30.65 Bn	27.34 Bn	992.69 Mn
7	Insmed	27.15 Bn	25.99 Bn	358.27 Mn
8	Royalty Pharma	26.98 Bn	26.14 Bn	-
9	BioNTech SE	26.78 Bn	8.39 Bn	668.28 Mn
10	Phio Pharmaceuticals	14.06 Mn	14.06 Mn	-

Download Data